Codexis, Inc.
CDXSHealthcare|Biotechnology|US
$1.08
+0.06 (+5.88%)
Tangible Book / Share
$0.33
Cash / Share
$0.60
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03797664 A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers | Healthy | P1 | Completed | 32 | RCT, Double-blind | CDX-6114, Placebo |
| NCT03577886 Safety and Tolerability of CDX-6114 in Healthy Volunteers | Healthy | P1 | Completed | 32 | RCT, Double-blind | CDX-6114, Placebo |